We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Mustang Bio
MBIO
$4.55M
| $539K | 0.08% |
1,227
-395
| -24% | -$219K |
|
452
Ryder
R
$10.1B
| $539K | 0.08% |
7,589
-2,687
| -26% | -$197K |
|
|
VBIV
453
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $539K | 0.08% |
22,235
+18,389
| +478% | +$626K |
|
454
Playtika
PLTK
$1.12B
| $538K | 0.08% |
40,605
+13,758
| +51% | +$214K |
|
455
Cheesecake Factory
CAKE
$5.33B
| $537K | 0.08% |
+20,324
| New | +$675K |
|
456
Manitowoc
MTW
$675M
| $534K | 0.08% |
50,729
-8,594
| -14% | -$108K |
|
|
WNS
457
DELISTED
WNS Holdings
WNS
| $534K | 0.08% |
7,158
+711
| +11% | +$54.3K |
|
458
Mercury Insurance
MCY
$6.07B
| $532K | 0.08% |
+12,017
| New | +$594K |
|
|
ME
459
DELISTED
23andMe Holding Co
ME
| $532K | 0.08% |
+10,719
| New | +$621K |
|
|
XM
460
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $532K | 0.08% |
42,550
+19,230
| +82% | +$342K |
|
461
Archrock
AROC
$5.8B
| $531K | 0.08% |
+64,156
| New | +$588K |
|
|
NOAH
462
Noah Holdings
NOAH
$603M
| $530K | 0.08% |
26,182
+7,193
| +38% | +$134K |
|
463
TTM Technologies
TTMI
$14.5B
| $530K | 0.08% |
+42,382
| New | +$586K |
|
464
National Fuel Gas
NFG
$7.65B
| $529K | 0.08% |
8,006
+3,087
| +63% | +$217K |
|
465
News Corp Class A
NWSA
$15.4B
| $529K | 0.08% |
33,946
+18,993
| +127% | +$349K |
|
|
TFFP
466
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $529K | 0.08% |
3,747
-469
| -11% | -$65.4K |
|
|
SPLK
467
DELISTED
Splunk Inc
SPLK
| $529K | 0.08% |
+5,977
| New | +$657K |
|
468
Trustmark
TRMK
$2.75B
| $528K | 0.08% |
18,094
+11,179
| +162% | +$323K |
|
469
Hasbro
HAS
$13.2B
| $527K | 0.08% |
6,438
-3,959
| -38% | -$343K |
|
470
NGL Energy Partners
NGL
$2.11B
| $527K | 0.08% |
346,613
-3,994
| -1% | -$7.84K |
|
471
Brilliant Earth
BRLT
$20.8M
| $526K | 0.08% |
+110,724
| New | +$695K |
|
472
MongoDB
MDB
$32.1B
| $526K | 0.08% |
2,026
+1,501
| +286% | +$469K |
|
|
AZRE
473
DELISTED
Azure Power Global Limited
AZRE
| $526K | 0.08% |
+46,099
| New | +$649K |
|
474
Pathward Financial
CASH
$1.83B
| $525K | 0.08% |
+13,586
| New | +$579K |
|
475
Gibraltar Industries
ROCK
$1.49B
| $525K | 0.08% |
13,561
+8,179
| +152% | +$334K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.